US DSCSA · §582 dispenser obligations · unit-level tracing in force · product without data is product you cannot accept.
For dispensers, DSCSA's enhanced phase turns receiving into a data checkpoint: product must arrive with matching electronic transaction data, suspect product must be quarantined and verified, and records must be producible on request. The pharmacies handling this well have made verification a scan, not a project.
Dispensers may only accept product with the required transaction information and statement — arriving electronically, matched to what is physically in the tote.
On suspicion — wrong seal, price too good, diverted lot — quarantine and investigate, verify the product identifier, and notify FDA and trading partners if illegitimate.
Transaction records must be maintained and producible (six years). In an investigation, the pharmacy that can answer in minutes is a partner; the one that cannot is a suspect.
Returns re-entering stock need verified identifiers. The wrong-item-in-the-right-box problem is not just an aftermarket disease — it walks through pharmacy returns too.
The dispenser obligations are live. The practical burden concentrates at receiving and returns — the two moments where physical product and electronic data must agree.
Verify identifiers against transaction data at the point of receipt — a phone or dock read, not a back-office reconciliation two weeks later.
Who quarantines, who verifies, who files the 3911 — decided before the day it happens. FDA expects a process, not improvisation.
Pull a random six-month-old transaction and reproduce its full record. If that takes longer than a coffee, fix the system before an investigator asks.
Aeroz makes the physical check instant: a tap or dock read verifies a unit's cryptographic identity against its EPCIS record — no new hardware beyond a phone, no line at receiving. For pharmacy groups, the same log answers investigators, narrows recalls to exact units on exact shelves, and keeps returns honest.
That product arrives with the required electronic transaction information and statement from an authorized trading partner, and that the physical product matches that data. Product without data is product you cannot accept.
Anything that casts doubt — packaging anomalies, implausible pricing, diverted or stolen-goods signals. The duty is to quarantine, investigate, verify the identifier, and notify FDA (Form 3911) plus partners if the product is illegitimate.
Six years, producible on request. Electronic, searchable records turn a subpoena into an export; paper turns it into a bad month.
Yes — if verification is a scan rather than a project. That is the design goal of Aeroz's dispenser deployment: phone-tap verification, automatic event logging, and records that assemble themselves.
A fixed-fee Aeroz audit maps your products against dscsa for dispensers requirements and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.